Technology News and Research

RSS

MicroConstants completes installation, qualification of new Xevo TQ-S tandem mass spectrometer

MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization in San Diego, California, announces today that it has successfully completed the installation and qualification of a new Xevo TQ-S tandem mass spectrometer from Waters Corporation.

3 Mar 2011

IBM announces new Patient Empowerment System

Today IBM announced the next evolution of the patient portal, significantly expanding the types of information, alerts, recommendations and interactive coaching healthcare providers can offer to their patients online.

3 Mar 2011

Protein serum amyloid A could be a potential diagnostic biomarker for lung cancer

Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease - difficult to diagnose in its earliest and most treatable stages - and to develop drugs that stop lung cancer from spreading. Their study appears in ACS's Journal of Proteome Research.

3 Mar 2011

Scientists devise new on-line calculator to predict food allergies in children

An on-line calculator that predicts, within seconds, the presence of the three major food allergies in children has been developed by researchers at University College Cork.

2 Mar 2011

ASU receives W. M. Keck $1 million grant to build next-generation 3D imaging microscope

The W. M. Keck Foundation has awarded Arizona State University a $1 million grant to the team of scientists led by Deirdre Meldrum, Ph.D., at the Biodesign Institute.

2 Mar 2011

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

The Translational Health Sciences and Technology Institute, an autonomous institute of the Indian government's Department of Biotechnology, and the International AIDS Vaccine Initiative announced today an agreement to jointly establish, operate and fund an HIV Vaccine Design Program in India.

2 Mar 2011

FDA clears Meridian's illumigene C. difficile molecular amplification test

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new pediatric claim for its illumigene C. difficile molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in severe cases, a life-threatening inflammation of the colon.

2 Mar 2011

International Surf Resorts to acquire BioZone Laboratories

International Surf Resorts, Inc., to be renamed BioZone Pharmaceuticals, Inc., today announced a binding option and letter of intent with BioZone Laboratories, Inc. and related companies.

2 Mar 2011

OZ Systems helps TEHDI program to provide latest newborn hearing screening equipment for midwives

OZ Systems today announced that it is helping the Texas Early Hearing Detection and Intervention Program facilitate an initiative that will provide the latest newborn hearing screening equipment to midwives across the state.

2 Mar 2011

Avvo launches new medical website for users to make physician search more effective

Avvo, the world's largest online directory for doctors and lawyers that provides free rankings for 90% of the working physicians in the U.S., continues to grow the number of service features offered on its medical website - to bring doctors and patients the latest, breakthrough online directory tools.

2 Mar 2011

UH Ahuja Medical Center officially opens its doors to patients on March 2

University Hospitals Ahuja Medical Center – the first new stand-alone hospital in Cuyahoga County in 30 years –officially opens its doors to patients on March 2.

2 Mar 2011

Allergan initiates AGN-214868 Phase II trials in post herpetic neuralgia and overactive bladder

Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.

2 Mar 2011

Thermo Fisher Scientific plans for new manufacturing facility in China

Thermo Fisher Scientific Inc., the world leader in serving science, today announced plans for a new manufacturing facility in China within the Suzhou Science and Technology Town - part of the company's strategy to aggressively expand its presence in the Asia-Pacific region.

From Thermo Fisher Scientific Inc. 2 Mar 2011

Accelr8 to present new BACcel test study results against hVISA in Europe

Accelr8 Technology Corporation announced that one of its outside principal investigators received acceptance to present results of a new study in Europe.

2 Mar 2011

AMIA releases position statement on EHR adoption and meaningful use

AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.

2 Mar 2011

Baxter announces European rMRP approval of PREFLUCEL seasonal influenza vaccine

Baxter International Inc. announced today the approval of a European repeat mutual recognition procedure (rMRP) by the Austrian Agency for Health and Food Safety for Baxter's PREFLUCEL seasonal influenza vaccine. The 13 participating European Union countries, including Germany, Spain, United Kingdom and Nordic countries, will formally implement the license on a national level to make PREFLUCEL available for the 2011-12 influenza season.

From Baxter International Inc. 2 Mar 2011

Scientists use pioneering technology to create safer drinking water in the U.S.

Pioneering technology by scientists at Queen's University Belfast, which is transforming the lives of millions of people in Asia, is now being used to create safer drinking water in the United States.

2 Mar 2011

GenMark announces dismissal of microfluidic technology patent lawsuit against Caliper Life Sciences

GenMark Diagnostics Inc. announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc.

2 Mar 2011

EPO to grant patent for Apricus MycoVa product to treat nail fungus

Apricus Biosciences, Inc. announced today that the European Patent Office will grant a patent for the company's MycoVa product for treating onychomycosis.

2 Mar 2011

Advion to establish new laboratory at Purdue Research Park near Indianapolis

Advion BioServices Inc., a provider of contract bioanalytical research services, announced that it will establish a laboratory here, creating 49 immediate jobs and up to 66 jobs by 2015.

From Advion 2 Mar 2011